About

This 90-minutes symposium was presented at NACFC Anaheim 2011, offering information on the current treatment options for patients with cystic fibrosis, as well as information on emerging therapies. The topics include: - CFTR gene modifiers: what are they & how they work - The importance of the CFTR genotype/phenotype interaction - The role of gene modifiers in determining CF presentations - Using gene-targeted therapies to implement individualized treatment